000 01332 a2200409 4500
005 20250513175434.0
264 0 _c19990615
008 199906s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-199904000-00018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMousa, S A
245 0 0 _aAlphavbeta3 integrin binding affinity and specificity of SM256 in various species.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cApr 1999
300 _a641-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBinding, Competitive
650 0 4 _aBiotinylation
650 0 4 _aDogs
650 0 4 _aHumans
650 0 4 _aIndazoles
_xmetabolism
650 0 4 _aIntegrins
_xantagonists & inhibitors
650 0 4 _aMice
650 0 4 _aRabbits
650 0 4 _aReceptors, Vitronectin
_xantagonists & inhibitors
650 0 4 _aSulfonamides
_xmetabolism
650 0 4 _aSwine
650 0 4 _aVitronectin
_xmetabolism
700 1 _aLorelli, W
700 1 _aMohamed, S
700 1 _aBatt, D G
700 1 _aJadhav, P K
700 1 _aReilly, T M
773 0 _tJournal of cardiovascular pharmacology
_gvol. 33
_gno. 4
_gp. 641-6
856 4 0 _uhttps://doi.org/10.1097/00005344-199904000-00018
_zAvailable from publisher's website
999 _c10177906
_d10177906